Fusen Pharmaceutical Company Limited (HKG:1652)

HKG:1652 Revenue

In the year 2025, Fusen Pharmaceutical Company had annual revenue of 273.37M CNY, down -16.15%. Fusen Pharmaceutical Company had revenue of 111.29M in the half year ending June 30, 2025, a decrease of -66.92%.

• Revenue: 273.37M CNY
• Revenue Growth: -16.15%
• P/S Ratio: 3.04
• Revenue / Employee: 261.59K CNY
• Employees: 1,045
• Market Cap: 924.13M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	273.37M	-52.66M	-16.15%
Dec 31, 2024	326.03M	-239.58M	-42.36%
Dec 31, 2023	565.61M	73.85M	15.02%
Dec 31, 2022	491.76M	106.09M	27.51%
Dec 31, 2021	385.66M	-101.19M	-20.78%